Europe PEGylated Proteins Market Size, Share & Industry Trends Analysis Report By Product & Services, By Type (Colony-stimulating Factor, Interferons, Recombinant Factor VII, Erythropoietin), By End-user, By Application, By Country and Growth Forecast, 2022 - 2028

The Europe PEGylated Proteins Market would witness market growth of 10.9% CAGR during the forecast period (2022-2028).

The main factors driving the growth are driving the demand for protein-based treatments, along with a boost in research activities for the creation of novel therapeutics and the benefits of PEGylated therapeutic proteins. Other important drivers include the rising incidence of degenerative & chronic diseases such as cancer, rheumatoid arthritis, and kidney disease.

The use of protein-based treatments has grown as a result of advancements in molecular biology engineering and biotechnology. In recent years, it has become quite apparent that there is an ever-increasing demand for recombinant proteins, including enzymes, hormones, growth factors, and monoclonal antibodies, among others.

Due to the therapeutic benefits of specificity and enhanced activity, biologics are now widely available and well-known among the affected community. For instance, the French biotechnology company LFB (Laboratoire Francais du Fractionnement et des Biotechnologies) received approval from the American FDA in April 2020 for a novel treatment for hemophilia.

In Europe, diabetes is growing more prevalent among individuals of all ages as a result of rising overweight and obesity rates, poor diets, and lack of physical activity. According to the World Health Organization, kidney failure accounts for 10 to 20% of cases of death for diabetics and accounts for 50% of deaths from cardiovascular disease (mostly heart disease and stroke). Approximately 60 million people in the European Region—10.3% of males and 9.6% of women over 25—have diabetes.

The Germany market dominated the Europe PEGylated Proteins Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $137.6 million by 2028.The UK market is experiencing CAGR of 9.9% during (2022 - 2028). Additionally, The France market would display a CAGR of 11.7% during (2022 - 2028).

Based on Product & Services, the market is segmented into Consumables and Services. Based on Type, the market is segmented into Colony-stimulating Factor, Interferons, Recombinant Factor VII, Erythropoietin and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Academic & Research Institutes. Based on Application, the market is segmented into Cancer, Autoimmune Diseases, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorders and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global PEGylated Proteins Market will Hit $2.1 Billion by 2028, at a CAGR of 11.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Millipore (Merck KGaA), Thermo Fisher Scientific, Inc., NOF Corporation, JenKem Technology Co. Ltd., Creative PEGworks, Celares GmbH, Quanta BioDesign, Ltd., Biomatrik, Inc., Iris Biotech GmbH, and Laysan Bio, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Product & Services

• Consumables
• Services

By Type

• Colony-stimulating Factor
• Interferons
• Recombinant Factor VII
• Erythropoietin
• Others

By End-user

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic & Research Institutes

By Application

• Cancer
• Autoimmune Diseases
• Hepatitis
• Multiple Sclerosis
• Hemophilia
• Gastrointestinal Disorders
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Merck Millipore (Merck KGaA)
• Thermo Fisher Scientific, Inc.
• NOF Corporation
• JenKem Technology Co. Ltd.
• Creative PEGworks
• Celares GmbH
• Quanta BioDesign, Ltd.
• Biomatrik, Inc.
• Iris Biotech GmbH
• Laysan Bio, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe PEGylated Proteins Market, by Product & Services
1.4.2 Europe PEGylated Proteins Market, by Type
1.4.3 Europe PEGylated Proteins Market, by End-user
1.4.4 Europe PEGylated Proteins Market, by Application
1.4.5 Europe PEGylated Proteins Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies Deployed in PEGylated Proteins Market

Chapter 4. Europe PEGylated Proteins Market by Product & Services
4.1 Europe Consumables Market by Country
4.2 Europe Services Market by Country

Chapter 5. Europe PEGylated Proteins Market by Type
5.1 Europe Colony-stimulating Factor Market by Country
5.2 Europe Interferons Market by Country
5.3 Europe Recombinant Factor VII Market by Country
5.4 Europe Erythropoietin Market by Country
5.5 Europe Others Market by Country

Chapter 6. Europe PEGylated Proteins Market by End-user
6.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
6.2 Europe Contract Research Organizations (CROs) Market by Country
6.3 Europe Academic & Research Institutes Market by Country

Chapter 7. Europe PEGylated Proteins Market by Application
7.1 Europe Cancer Market by Country
7.2 Europe Autoimmune Diseases Market by Country
7.3 Europe Hepatitis Market by Country
7.4 Europe Multiple Sclerosis Market by Country
7.5 Europe Hemophilia Market by Country
7.6 Europe Gastrointestinal Disorders Market by Country
7.7 Europe Others Market by Country

Chapter 8. Europe PEGylated Proteins Market by Country
8.1 Germany PEGylated Proteins Market
8.1.1 Germany PEGylated Proteins Market by Product & Services
8.1.2 Germany PEGylated Proteins Market by Type
8.1.3 Germany PEGylated Proteins Market by End-user
8.1.4 Germany PEGylated Proteins Market by Application
8.2 UK PEGylated Proteins Market
8.2.1 UK PEGylated Proteins Market by Product & Services
8.2.2 UK PEGylated Proteins Market by Type
8.2.3 UK PEGylated Proteins Market by End-user
8.2.4 UK PEGylated Proteins Market by Application
8.3 France PEGylated Proteins Market
8.3.1 France PEGylated Proteins Market by Product & Services
8.3.2 France PEGylated Proteins Market by Type
8.3.3 France PEGylated Proteins Market by End-user
8.3.4 France PEGylated Proteins Market by Application
8.4 Russia PEGylated Proteins Market
8.4.1 Russia PEGylated Proteins Market by Product & Services
8.4.2 Russia PEGylated Proteins Market by Type
8.4.3 Russia PEGylated Proteins Market by End-user
8.4.4 Russia PEGylated Proteins Market by Application
8.5 Spain PEGylated Proteins Market
8.5.1 Spain PEGylated Proteins Market by Product & Services
8.5.2 Spain PEGylated Proteins Market by Type
8.5.3 Spain PEGylated Proteins Market by End-user
8.5.4 Spain PEGylated Proteins Market by Application
8.6 Italy PEGylated Proteins Market
8.6.1 Italy PEGylated Proteins Market by Product & Services
8.6.2 Italy PEGylated Proteins Market by Type
8.6.3 Italy PEGylated Proteins Market by End-user
8.6.4 Italy PEGylated Proteins Market by Application
8.7 Rest of Europe PEGylated Proteins Market
8.7.1 Rest of Europe PEGylated Proteins Market by Product & Services
8.7.2 Rest of Europe PEGylated Proteins Market by Type
8.7.3 Rest of Europe PEGylated Proteins Market by End-user
8.7.4 Rest of Europe PEGylated Proteins Market by Application

Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.2 Merck Millipore ( Merck Group)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.3 NOF Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.4 Beijing Jiankai Technology Co., Ltd. (Jenkem)
9.4.1 Company Overview
9.5 Creative PEGworks
9.5.1 Company Overview
9.6 Celares GmbH
9.6.1 Company Overview
9.7 Quanta BioDesign Ltd.
9.7.1 Company Overview
9.8 Biomatrik, Inc.
9.8.1 Company Overview
9.9 Iris Biotech GmbH
9.9.1 Company Overview
9.10. Laysan Bio, Inc.
9.10.1 Company Overview

TABLE 1 Europe PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 2 Europe PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 3 Europe PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 4 Europe PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 5 Europe Consumables Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Consumables Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Services Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Services Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 10 Europe PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 11 Europe Colony-stimulating Factor Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Colony-stimulating Factor Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Interferons Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Interferons Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Recombinant Factor VII Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Recombinant Factor VII Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 22 Europe PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 23 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 24 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 25 Europe Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 30 Europe PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 31 Europe Cancer Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Cancer Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Autoimmune Diseases Market by Country, 2018 - 2021, USD Million
TABLE 34 Europe Autoimmune Diseases Market by Country, 2022 - 2028, USD Million
TABLE 35 Europe Hepatitis Market by Country, 2018 - 2021, USD Million
TABLE 36 Europe Hepatitis Market by Country, 2022 - 2028, USD Million
TABLE 37 Europe Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
TABLE 38 Europe Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
TABLE 39 Europe Hemophilia Market by Country, 2018 - 2021, USD Million
TABLE 40 Europe Hemophilia Market by Country, 2022 - 2028, USD Million
TABLE 41 Europe Gastrointestinal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 42 Europe Gastrointestinal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 43 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 44 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 45 Europe PEGylated Proteins Market by Country, 2018 - 2021, USD Million
TABLE 46 Europe PEGylated Proteins Market by Country, 2022 - 2028, USD Million
TABLE 47 Germany PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 48 Germany PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 49 Germany PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 50 Germany PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 51 Germany PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 52 Germany PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 53 Germany PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 54 Germany PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 55 Germany PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 56 Germany PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 57 UK PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 58 UK PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 59 UK PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 60 UK PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 61 UK PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 62 UK PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 63 UK PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 64 UK PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 65 UK PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 66 UK PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 67 France PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 68 France PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 69 France PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 70 France PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 71 France PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 72 France PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 73 France PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 74 France PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 75 France PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 76 France PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 77 Russia PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 78 Russia PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 79 Russia PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 80 Russia PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 81 Russia PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 82 Russia PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 83 Russia PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 84 Russia PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 85 Russia PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 86 Russia PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 87 Spain PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 88 Spain PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 89 Spain PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 90 Spain PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 91 Spain PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 92 Spain PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 93 Spain PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 94 Spain PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 95 Spain PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 96 Spain PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 97 Italy PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 98 Italy PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 99 Italy PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 100 Italy PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 101 Italy PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 102 Italy PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 103 Italy PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 104 Italy PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 105 Italy PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 106 Italy PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 107 Rest of Europe PEGylated Proteins Market, 2018 - 2021, USD Million
TABLE 108 Rest of Europe PEGylated Proteins Market, 2022 - 2028, USD Million
TABLE 109 Rest of Europe PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
TABLE 110 Rest of Europe PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
TABLE 111 Rest of Europe PEGylated Proteins Market by Type, 2018 - 2021, USD Million
TABLE 112 Rest of Europe PEGylated Proteins Market by Type, 2022 - 2028, USD Million
TABLE 113 Rest of Europe PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
TABLE 114 Rest of Europe PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
TABLE 115 Rest of Europe PEGylated Proteins Market by Application, 2018 - 2021, USD Million
TABLE 116 Rest of Europe PEGylated Proteins Market by Application, 2022 - 2028, USD Million
TABLE 117 Key Information – Thermo Fisher Scientific, Inc.
TABLE 118 Key Information – Merck Millipore
TABLE 119 Key Information – nof corporation
TABLE 120 Key Information – Beijing Jiankai Technology Co., Ltd.
TABLE 121 Key Information – Creative PEGworks
TABLE 122 Key Information – Celares gmbh
TABLE 123 Key Information –Quanta biodesign ltd.
TABLE 124 Key Information – biomatrik, inc.
TABLE 125 Key Information – Iris biotech gmbh
TABLE 126 Key Information – laysan bio, inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Thermo Fisher Scientific, Inc.